prix: $0.16937 -0.7165%
Valeur marchande: 25.14B 0.9322%
Chiffre d’affaires (24h): 1.26B 0%
Dominance: 0.9322%
Price: $0.16937 -0.7165%
Valeur marchande: 25.14B 0.9322%
Chiffre d’affaires (24h): 1.26B 0%
Dominance: 0.9322% 0.9322%
  • prix: $0.16937 -0.7165%
  • Valeur marchande: 25.14B 0.9322%
  • Chiffre d’affaires (24h): 1.26B 0%
  • Dominance: 0.9322% 0.9322%
  • prix: $0.16937 -0.7165%
  • Jan / 06
    • Pièces mèmes à venir : PEPETO, DOGE, SHIB et autres jetons disponibles à l'achat en 2025
      Jan 06, 2025 at 10:03 pm Crypto Daily™
      Meme coins, initially dismissed as internet jests, have emerged as potent financial instruments with practical uses, engaged communities, and compelling storylines. Prominent meme coins such as PEPETO, DOGE, and SHIB have established a strong presence in the crypto market, offering substantial growth potential for investors.
    • DOGEcoin (DOGE) Prévision de prix pour le 6 janvier
      Jan 06, 2025 at 08:42 pm BlockchainReporter
      Dogecoin (DOGE) has rebounded from recent losses, exceeding the $0.32 threshold and trading at $0.385, marking a 0.82% daily gain. The memecoin's rally echoes its 250% surge in 2024, reaching $0.39, a level unseen since 2021. Despite facing resistance at $0.39, DOGE has consolidated beneath it, with support levels identified at $0.35 and $0.285. Price projections for 2025 vary, with some analysts predicting a range of $2.35 to $2.60, while others anticipate a more conservative growth within a range of $0.25 to $0.39.
    • Shiba Inu, un jeton qui surpasse DOGE, passera de 155 $ à 15 500 $ en 10 semaines
      Jan 06, 2025 at 07:40 pm crypto.news
      Rexas Finance outshines Dogecoin and Shiba Inu by leveraging real-world asset tokenization, boosting its ROI potential. Despite unappealing returns projected for DOGE and SHIB, Rexas presents exceptional growth opportunities, having raised over $34 million in presales and secured a CertiK audit. Its innovative approach and listing on major exchanges like CoinMarketCap and CoinGecko solidify its credibility. Analysts predict a 100x surge, with RXS poised to benefit from increased investor interest in emerging tokens.

Sélectionnez la devise

Sélectionnez la devise